semaglutide litigation Rybelsus Lawsuit - July 2026 Update The GLP-1 RA Legal Timeline:
Description
When semaglutide branded as Wegovy was first approved in 2021, weight loss was the only indication on its label
L., Wong, G., DRozario, A
Beyond weight loss, benefits extend to improving health metrics related to heart health and diabetes
Patients using semaglutide have experienced reductions in total cholesterol, LDL cholesterol, and triglycerides, likely due to its effects on weight loss and improved glycemic control
Integrating Semaglutide with Lifestyle Modifications For optimal results, Semaglutide should be used in conjunction with lifestyle modifications, including a reduced-calorie diet and increased physical activity
